The Carlyle Group is increasing its investment activity in china with a new joint-venture.
The Washington, D.C.-based private equity giant and Fosun Group, which manages more than US$10 billion, have launched a US$100 million global growth fund. The new vehicle, which is denominated in Chinese yuan, will invest in high-growth companies around the world.
Carlyle and Shanghai-based Fosun already jointly invest in a Chinese baby formula company.
Carlyle also announced plans for future yuan-denominated funds.
“By working with local partners like Fosun, we expect to make investments that benefit high-growth companies and enhance the local private equity industry,” Carlyle co-founder David Rubenstein said.